Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
This study has been terminated.
Sponsor:
Threshold Pharmaceuticals
Collaborator:
PRA International
Information provided by:
Threshold Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00435448
First received: February 8, 2007
Last updated: April 28, 2009
Last verified: April 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | December 2006 |
| Primary Completion Date: | December 2006 (Final data collection date for primary outcome measure) |